Michael Chorev

8.3k total citations
169 papers, 6.5k citations indexed

About

Michael Chorev is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael Chorev has authored 169 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Molecular Biology, 50 papers in Organic Chemistry and 37 papers in Oncology. Recurrent topics in Michael Chorev's work include Chemical Synthesis and Analysis (78 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). Michael Chorev is often cited by papers focused on Chemical Synthesis and Analysis (78 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). Michael Chorev collaborates with scholars based in United States, Israel and Italy. Michael Chorev's co-authors include Murray Goodman, Michael Rosenblatt, José A. Halperin, Alessandro Bisello, Chaim Gilon, Dale F. Mierke, Zvi Selinger, Itai Bab, Maria Pellegrini and Vered Behar and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Chorev

167 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Chorev United States	45	4.6k	1.3k	1.1k	977	499	169	6.5k
Chaim Gilon Israel	45	5.7k 1.3×	1.7k 1.3×	1.3k 1.3×	1.5k 1.6×	602 1.2×	228	8.7k
Shumpei Sakakibara Japan	48	5.0k 1.1×	969 0.7×	1.2k 1.1×	1.7k 1.8×	271 0.5×	210	7.9k
Akira Otaka Japan	50	4.6k 1.0×	2.6k 1.9×	1.5k 1.5×	693 0.7×	581 1.2×	225	7.9k
Matthias Eckhardt Germany	41	3.5k 0.8×	1.2k 0.9×	489 0.5×	901 0.9×	215 0.4×	103	6.0k
Loren D. Walensky United States	49	9.4k 2.1×	1.5k 1.1×	1.9k 1.8×	655 0.7×	607 1.2×	122	11.3k
George D. Hartman United States	40	2.5k 0.6×	1.7k 1.3×	508 0.5×	600 0.6×	319 0.6×	183	5.4k
Thomas J. Wandless United States	40	5.9k 1.3×	892 0.7×	1.2k 1.1×	727 0.7×	229 0.5×	76	7.9k
Jianming Xie United States	30	2.6k 0.6×	685 0.5×	517 0.5×	412 0.4×	346 0.7×	51	4.4k
David C. Turner United States	42	3.0k 0.7×	490 0.4×	616 0.6×	468 0.5×	306 0.6×	123	5.5k
Carsten Schultz Germany	55	6.6k 1.4×	2.4k 1.8×	462 0.4×	1.1k 1.2×	704 1.4×	221	10.4k

Countries citing papers authored by Michael Chorev

Since Specialization

Citations

This map shows the geographic impact of Michael Chorev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chorev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chorev more than expected).

Fields of papers citing papers by Michael Chorev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chorev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chorev. The network helps show where Michael Chorev may publish in the future.

Co-authorship network of co-authors of Michael Chorev

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chorev. A scholar is included among the top collaborators of Michael Chorev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chorev. Michael Chorev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chorev, Michael, et al.. (2024). Activity of the Di-Substituted Urea-Derived Compound I-17 in Leishmania In Vitro Infections. Pathogens. 13(2). 104–104. 1 indexed citations

Papadopoulos, Evangelos, Simon Jenni, Khuloud Takrouri, et al.. (2014). Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G. Proceedings of the National Academy of Sciences. 111(31). E3187–95. 72 indexed citations

Hu, Weiguo, Xiaowen Ge, Tao You, et al.. (2011). Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis. Cancer Research. 71(6). 2298–2307. 74 indexed citations

Rovero, Paolo, et al.. (2008). Building blocks for the synthesis of post‐translationally modified glycated peptides and proteins. Journal of Peptide Science. 15(2). 67–71. 14 indexed citations

Hyberts, Sven G., Gregory J. Heffron, Kirty S. Solanky, et al.. (2007). Ultrahigh-Resolution ¹ H− ¹³ C HSQC Spectra of Metabolite Mixtures Using Nonlinear Sampling and Forward Maximum Entropy Reconstruction. Journal of the American Chemical Society. 129(16). 5108–5116. 114 indexed citations

Moerke, Nathan J., Hüseyin Aktaş, Han Chen, et al.. (2007). Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G. Cell. 128(2). 257–267. 441 indexed citations

Gabet, Yankel, Ralph Müller, Eran Regev, et al.. (2004). Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone. 35(1). 65–73. 98 indexed citations

Bisello, Alessandro, Michael Chorev, Michael Rosenblatt, et al.. (2002). Selective Ligand-induced Stabilization of Active and Desensitized Parathyroid Hormone Type 1 Receptor Conformations. Journal of Biological Chemistry. 277(41). 38524–38530. 79 indexed citations

Gavish, Hanna, András Mühlrád, Yuchen Chen, et al.. (2001). Mitogenic G_i protein‐MAP kinase signaling cascade in MC3T3‐E1 osteogenic cells: Activation by C‐terminal pentapeptide of osteogenic growth peptide [OGP(10–14)] and attenuation of activation by cAMP. Journal of Cellular Biochemistry. 81(4). 594–603. 58 indexed citations

10.

Schievano, Elisabetta, Stefano Mammi, Vered Behar, et al.. (2000). Conformational studies of parathyroid hormone (PTH)/PTH-related protein (PTHrp) chimeric peptides. Biopolymers. 54(6). 429–447. 11 indexed citations

11.

Behar, Vered, Alessandro Bisello, Michael Rosenblatt, & Michael Chorev. (1999). Direct Identification of Two Contact Sites for Parathyroid Hormone (PTH) in the Novel PTH-2 Receptor using Photoaffinity Cross-Linking1. Endocrinology. 140(9). 4251–4261. 32 indexed citations

12.

Zor, Tsaffrir, et al.. (1998). GTP analogue hydrolysis by the Gs protein: implication for the role of catalytic glutamine in the GTPase reaction. FEBS Letters. 433(3). 326–330. 18 indexed citations

13.

Chorev, Michael, et al.. (1995). Conformation and interactions of bombolitin I analogues with SDS micelles and phospholipid vesicles: CD, fluorescence, two‐dimensional NMR and computer simulations. Biopolymers. 36(4). 473–484. 16 indexed citations

14.

Arad, Gila, et al.. (1995). Avian Sarcoma Leukemia Virus Protease Linked to the AdjacentGagPolyprotein Is Enzymatically Active. Virology. 214(2). 439–444. 6 indexed citations

15.

Chorev, Michael, Richard M. Epand, Michael Rosenblatt, & Michael P. Caulfield. (1993). Circular dichroism (CD) studies of antagonists derived from parathyroid hormone‐related protein. International journal of peptide & protein research. 42(4). 342–345. 12 indexed citations

16.

Greenberg, Zvi, et al.. (1993). Mitogenic action of osteogenic growth peptide (OGP) Role of amino and carboxy-terminal regions and charge. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1178(3). 273–280. 39 indexed citations

17.

Chorev, Michael, et al.. (1991). Toward nonpeptidal substance P mimetic analogues: Design, synthesis, and biological activity. Biopolymers. 31(6). 725–733. 8 indexed citations

18.

Rayan, Anwar, et al.. (1991). Theoretical Models of Aspartic Proteases: Active Site Properties, Dimer Stability and Interactions with Model Inhibitors. Advances in experimental medicine and biology. 306. 555–558. 2 indexed citations

19.

Goldman, Mark E., Michael Chorev, Jane E. Reagan, et al.. (1988). Evaluation of Novel Parathyroid Hormone Analogs Using a Bovine Renal Membrane Receptor Binding Assay. Endocrinology. 123(3). 1468–1475. 57 indexed citations

20.

Frey, Joseph M., Ralph Laufer, Chaim Gilon, et al.. (1987). Behavioural effects of receptor-specific substance P agonists. Pain. 31(2). 263–276. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact